Who are we?

Cyclica is a pioneer in the development of next generation in silico discovery and testing technologies that leverage integrated biological data to improve pharma R&D productivity. The company is commercializing the Ligand Explorer™ to addresses the rising cost of R&D in drug discovery and low regulatory approval rates of pre-market pharmaceutical and biopharmaceutical products. Using cloud computing approach, Cyclica’s powerful Ligand Explorer™ platform reduces the failure risk of drug discovery projects by allowing clients to anticipate a drug candidate’s side effects prior to clinical trials, thereby enabling more informed R&D investment decisions. Furthermore, the technology allows researchers to overcome expensive project hurdles with data-guided Intelligent Molecular Redesign™.

Drug Discovery News Feeds